Abstract
The burst of reprogramming technology in recent years has revolutionized the field of stem cell biology, offering new opportunities for personalized, regenerative therapies. The direct reprogramming of somatic cells to induced pluripotent stem cells (iPSCs) has provided an invaluable tool to study and model a wide range of human diseases. Here, we review the transforming potential of such a strategy in research and in therapies applicable to the hematology field.
| Original language | English |
|---|---|
| Article number | 7 |
| Journal | Cells |
| Volume | 6 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 8 Mar 2017 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Blood diseases
- Cancer
- Regenerative medicine
- Reprogramming
Fingerprint
Dive into the research topics of 'Application of induced pluripotent stem cell technology to the study of hematological diseases'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver